# Alcon to acquire STAAR Surgical for $1.5 billion

Alcon agreed to acquire all outstanding shares of STAAR Surgical for $28 per share in cash, valuing STAAR at approximately $1.5 billion in equity value. STAAR is a leader in refractive surgery using Implantable Collamer Lenses.

- Type: Acquisition
- Announced: 2025-08-05
- Value: $1.50B
- Status: announced
- Products: Implantable Collamer Lenses (ICL), EVO family of lenses
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Alcon Group](https://endata.com/companies/16712.md) (acquirer)
- [STAAR Surgical](https://endata.com/companies/86423.md) (target)

## Sources

- [investors.staar.com](https://investors.staar.com/news-and-events/press-releases/2025/08-04-2025), 2025-08-05: "The acquisition of STAAR enhances our ability to offer a leading surgical vision correction solution for those who are not ideal candidates for other refractive surgeries such as LASIK."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.